Kirchgessner C U, Warren S T, Willard H F
Department of Genetics, Stanford University School of Medicine, CA 94305, USA.
J Med Genet. 1995 Dec;32(12):925-9. doi: 10.1136/jmg.32.12.925.
X chromosome inactivation has been hypothesised to play a role in the aetiology and clinical expression of the fragile X syndrome. The identification of the FMR1 gene involved in fragile X syndrome allows testing of the assumption that the fragile X locus is normally subject to X inactivation. We studied the expression of the FMR1 gene from inactive X chromosomes by reverse transcription of RNA followed by PCR (RT-PCR), both in somatic cell hybrids which retain an active or inactive human X chromosome and in a female patient with a large deletion surrounding the FMR1 gene. In both analyses, the data indicate that FMR1 is not normally expressed from the inactive X chromosome and is, therefore, subject to X chromosome inactivation. This finding is consistent with the results of previous studies of DNA methylation of FMR1 on active and inactive X chromosomes, verifies previous assumptions about the fragile X locus, and supports the involvement of X inactivation in the variable phenotype of females with full mutations of the FMR1 gene.
已有假说认为,X染色体失活在脆性X综合征的病因学及临床表型中发挥作用。脆性X综合征相关FMR1基因的鉴定,使得对脆性X位点通常会发生X染色体失活这一假设进行检验成为可能。我们通过RNA逆转录后进行PCR(RT-PCR),研究了来自失活X染色体的FMR1基因的表达情况,研究对象包括保留有活性或失活人类X染色体的体细胞杂种,以及一名FMR1基因周围存在大片段缺失的女性患者。在两项分析中,数据均表明FMR1通常不会从失活的X染色体上表达,因此,它会发生X染色体失活。这一发现与之前对活性和失活X染色体上FMR1基因DNA甲基化的研究结果一致,证实了之前关于脆性X位点的假设,并支持X染色体失活参与FMR1基因完全突变女性可变表型的观点。